Enfusion

Enfusion FCF Yield

Delisted

The Free Cash Flow Yield of Enfusion (ENFN) as of Nov 7, 2026 is 2.22 %. In the previous year, Free Cash Flow Yield was 1.14 % — a change of 94.49% (higher).

FCF Yield

2.22 %

YoY

94.49%

Last updated:

Free Cash Flow Yield of Enfusion is 2024 2.22 % . Free Cash Flow Yield of Enfusion was 2023 1.14 % . It decreases by 94.49% higher compared to the previous year.

The Enfusion FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2019
0.56 USD
Jan 1, 2020
-0.24 USD
Jan 1, 2021
-0.60 USD
Jan 1, 2022
0.45 USD
Jan 1, 2023
1.14 USD
Jan 1, 2024
2.22 USD
The Enfusion FCF Yield history
YEARFCF YieldYoY
2.22 %+94.49%
1.14 %+156.43%
0.45 %-174.71%
-0.60 %+144.84%
-0.24 %-143.20%
0.56 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Free Cash Flow Yield of Enfusion is 2.22 % in 2024.

Free Cash Flow Yield of Enfusion changed from 1.14 % to 2.22 %, representing a 94.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Enfusion since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Enfusion with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Enfusion

All Key Metrics — Enfusion